Understanding Kleine-Levin Syndrome Sleeping Beauty Syndrome By: Mariam Mubarak Saeed Sayyah

 



Understanding Kleine-Levin Syndrome (Sleeping Beauty Syndrome): A Rare

Disorder of Recurrent Excessive Sleep


Introduction-

Kleine-Levin Syndrome (KLS), often called Sleeping Beauty Syndrome, is a rare

neurological disorder that causes repeated episodes of excessive sleep. During these

episodes, individuals may sleep for up to 20 hours a day and experience changes in

behavior, thinking, and appetite. Episodes can last for several days or even weeks

before symptoms disappear, allowing the person to return to their normal daily life.

Although KLS is extremely rare, it can have a major impact on education, employment,

relationships, and mental health. Because the disorder is uncommon and often

misunderstood, many patients experience delayed diagnosis or are mistaken for having

psychiatric conditions. KLS mainly affects adolescents, especially teenage boys, but it

can occur in people of any age or gender.


Causes-

The exact cause of Kleine-Levin Syndrome is still unknown. Researchers believe it may

involve abnormalities in the hypothalamus, a part of the brain that controls sleep,

appetite, body temperature, and hormones.

Possible contributing factors include:

 Genetic susceptibility

 Autoimmune reactions, in which the immune system mistakenly attacks healthy

brain tissue

 Viral infections, such as influenza, which sometimes occur before the first

episode

 Brain inflammation affecting regions involved in sleep regulation

More research is needed to determine the exact cause of the disorder.


Symptoms-

The hallmark symptom of KLS is recurrent episodes of excessive sleep

(hypersomnia).

During an episode, patients may experience:

 Sleeping 15–20 hours per day

 Extreme drowsiness

 Difficulty waking up


 Confusion and disorientation

 Poor concentration and memory

 Irritability

 Changes in behavior or personality

 Increased appetite (hyperphagia)

 Strong cravings for sweets or unusual foods

 In some cases, increased sexual behavior (hypersexuality), which is reported

more often in males

Between episodes, patients usually return to their normal physical and mental health

without any symptoms.


Diagnosis-

There is no single test that can diagnose Kleine-Levin Syndrome. Instead, doctors

diagnose it by carefully reviewing the patient's medical history and ruling out other

conditions with similar symptoms.


Tests may include:

 Physical and neurological examinations

 Blood tests

 Brain MRI scans

 Electroencephalogram (EEG)

 Sleep studies (polysomnography)

 Psychological evaluation to exclude psychiatric disorders

A diagnosis is usually made when a patient has repeated episodes of excessive sleep

along with characteristic behavioral and cognitive changes.


Treatments-

There is currently no cure for Kleine-Levin Syndrome. Treatment focuses on reducing

symptoms and helping patients manage episodes.

Possible treatments include:

 Supportive care during episodes

 Ensuring the patient remains safe while sleeping excessively


 Stimulant medications (such as modafinil or amphetamines) to reduce daytime

sleepiness in some patients

 Mood stabilizers, including lithium, which may reduce the frequency of episodes

in certain individuals

 Counseling and educational support to help patients and families cope with the

condition

Treatment effectiveness varies from person to person.


Current Research-

Researchers continue to investigate the causes of KLS and search for more effective

treatments.


Current research focuses on:

 The role of the immune system in triggering episodes

 Brain imaging studies to identify affected brain regions

 Genetic factors that may increase the risk of developing KLS

 New medications that may shorten or prevent episodes

Although research is ongoing, the rarity of the disorder makes large clinical studies

difficult.


Patient Impact-

Kleine-Levin Syndrome can significantly affect a person's education, career, and social

life.

Frequent episodes may cause students to miss weeks of school, leading to academic

difficulties. Adults may struggle to maintain employment because episodes occur

without warning. Patients may also experience anxiety, depression, and frustration due

to the unpredictable nature of the disorder.

Families often face emotional and financial challenges while caring for loved ones

during prolonged episodes. Because patients appear healthy between episodes, others

may not fully understand the seriousness of the condition.


Statistics-

 KLS affects approximately 1 to 5 people per million worldwide.

 Around 70% of patients are male.

 Symptoms usually begin during adolescence, most commonly between 10 and

20 years of age.

 Episodes may occur several times a year and often become less frequent over

time.

 In many patients, the disorder gradually resolves after 10–20 years, although the

duration varies.


Why Awareness Matters-

Kleine-Levin Syndrome is often misunderstood because patients appear completely

healthy between episodes. Many are initially misdiagnosed with depression, epilepsy, or

psychiatric disorders, delaying appropriate care.

Increasing awareness can help healthcare providers recognize the condition earlier,

reduce unnecessary testing, and provide better support for patients and families.

Greater awareness also encourages funding for research, which may lead to improved

treatments and a better understanding of the disorder.

Supporting individuals with KLS through education, workplace accommodations, and

emotional support can greatly improve their quality of life.


Conclusion-

Kleine-Levin Syndrome is a rare neurological disorder characterized by repeated

episodes of excessive sleep and changes in behavior, thinking, and appetite. Although

there is currently no cure, proper diagnosis, supportive care, and ongoing research offer

hope for better treatments in the future. Raising awareness of KLS is essential to

improving patient care, reducing stigma, and advancing scientific research into this

unusual condition.


Sources (APA 7th Edition)-

Arnulf, I., Lin, L., Gadoth, N., File, J., Lecendreux, M., Franco, P., Zeitzer, J. M., Lo, B.,

Faraco, J., & Mignot, E. (2008). Kleine-Levin syndrome: A systematic review of 186

cases in the literature. Brain, 131(11), 2763–2776. https://doi.org/10.1093/brain/awn168

National Organization for Rare Disorders. (2024). Kleine-Levin syndrome.

https://rarediseases.org/rare-diseases/kleine-levin-syndrome/

National Institute of Neurological Disorders and Stroke. (2024). Kleine-Levin syndrome.

https://www.ninds.nih.gov

MedlinePlus Genetics. (2024). Kleine-Levin syndrome. https://medlineplus.gov


Cleveland Clinic. (2024). Kleine-Levin syndrome (Sleeping Beauty syndrome).

https://my.clevelandclinic.org/health/diseases/23484-kleine-levin-syndrome

Comments

Post a Comment

Popular posts from this blog

Understanding Ehlers-Danlos Syndrome (EDS) By: Zella Shanks (Current Campaign)

Image
  Introduction   What is Ehlers-Danlos Syndrome (EDS)? Ehlers-Danlos Syndrome, also known as EDS, is a group of genetic disorders that affect the body’s connective tissues. Connective tissue is found almost everywhere in the body and helps hold everything together, including your own skin, joints, muscles, and blood vessels. People that have Ehlers-Danlos Syndrome have problems with collagen, which is one of the many main proteins that gives connective tissues its strength and flexibility. When collagen doesn’t work the way it’s supposed to, the body’s tissues become weaker and more likely to stretch or to get injured. Why Is It Important?    Even though EDS isn’t very well known, it can have a huge effect on someone’s everyday life. Many people deal with ongoing pain, fatigue, joint injuries, and other symptoms that can make normal activities more difficult. While there isn’t a cure yet, getting diagnosed early and learning how to manage the condition can ...
Read more

Uncovering the Clinical Characterization and Mechanisms of Fibrodysplasia Ossificans Progressiva (FOP) By: Sharen Rego

Image
 Introduction Fibrodysplasia Ossificans Progressiva or FOP is an exceedingly rare, yet severely disabling genetic disorder, characterized by the abnormal formation of bone tissue outside of the normal human skeleton (heterotopic ossification). This can occur within soft tissues like the skeletal muscles, tendons, and ligaments. With an estimated one in two million people affected globally, FOP represents one of the most complex genetic conditions known to modern medicine. Raising awareness for this disorder is crucial, as early symptoms are often misdiagnosed as cancer, leading to harmful medical interventions like biopsies or routine muscle injections which trigger irreversible bone growth. Main Body At the cellular level, FOP is caused by a specific mutation in the ACVR1 gene located on chromosome 2. This gene provides instructions for making a specialized receptor protein that controls when and where the body builds bone tissue (such as during fetal development or when healing a...
Read more

Understanding Cystic Fibrosis

Image
Blog written by Alyza Kour - Reasearch Lead of Teen Med Spot   Mucus in our body is more than just “gross stuff” coming out our nose when we have a cold, it’s actually a vital protective layer. Its job is to line our lungs, digestive tract, and other organs to keep them moist and to trap dust, bacteria, or virusese so your body can get rid of them. Healthy mucus is thin, slippery, and water (Think of it like a layer of liquid soap). ( Cleveland Clinic ) What is cystic fibrosis? It is a genetic disease that causes sticky, thick mucus to build up in your organs (Lungs, Digestive System, Pancreas), blocking and damaging them. ( Cleveland Clinic.org ) What causes cystic fibrosis? Changes to the CFTR gene - called variants or mutations - cause cystic fibrosis. CFTR makes a protein that works as an ion channel on the surface of a cell. Ion channels are like gates in a cell’s membrane that allow certain molecules to pass through. Think of this protein as a “gate” for chloride ions (sa...
Read more